Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: A proof of concept
10.1038/tp.2011.22
Saved in:
Main Authors: | Kaddurah-Daouk, R., Boyle, S.H., Matson, W., Sharma, S., Matson, S., Zhu, H., Bogdanov, M.B., Churchill, E., Krishnan, R.R., Rush, A.J., Pickering, E., Delnomdedieu, M. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110228 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder - Possible Role for Methoxyindole Pathway
by: Zhu, H., et al.
Published: (2014) -
Opioid use affects antioxidant activity and purine metabolism: Preliminary results
by: Mannelli, P., et al.
Published: (2014) -
Alterations in tryptophan and purine metabolism in cocaine addiction: A metabolomic study
by: Patkar, A.A., et al.
Published: (2014) -
Is there a place for placebo in management of psychogenic movement disorders?
by: Lim, E.C.-H., et al.
Published: (2011) -
Is there a place for placebo in management of psychogenic movement disorders?
by: Lim, E.C.H., et al.
Published: (2016)